GreenLight™ Laser Therapy
Has the medication prescribed by your doctor stopped doing its job? It may be time to consider an alternative.
What do patients say?
GreenLight Laser Therapy has helped more than 1 million men around the world relieve the symptoms of BPH.1 And get back to life.
Guys don’t typically talk about things like BPH. Even with their partners, friends, family or personal doctor. Until it starts getting in the way. Of work, sleep, sex, everything. Hear firsthand from men who battled BPH—until this innovative treatment gave them new hope. And a better life.
- Data on file with Boston Scientific.
- Sohn JH, Choi YS, Kim SJ, Effectiveness and safety of photoselective vaporization of the prostate with the 120 W HPS GreenLight laser in benign prostatic hyperplasia patients taking oral anticoagulants. Korean J Urol. 2011 Mar;52(3):178-83.
- GreenLight XPS™ Laser System Operator’s Manual, Part No. 0010-0240 Rev. C. November 2010.
- Bachmann A, Tubaro A, Barber N, et al. 180-W XPS GreenLight laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of the European multi-centre randomized trial – The GOLIATH Study. Eur Urol. 2014 May;65(5):931-42.
- Lukacs B, Loeffler J, Bruyère F, et al. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: A multicenter randomized controlled trial. Eur Urol. 2012;61(6):1165-73.
- Capitán C, Blázquez C, Martin MD, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: A randomized clinical trial with 2-year follow-up. Eur Urol. 2011 Oct;60(4):734-9.
- Al-Ansari A, Younes N, Sampige VP, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol. 2010 Sep;58(3):349-55.
- Bouchier-Hayes DM, Van Appledorn S, Bugeja P, et al. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int. 2010 Apr;105(7):964-9.
- Garnick MB. 2013 Annual Report on Prostate Diseases. Boston, MA: Harvard Health Publications; 2013.
- Ajib K, Mansour M, Zanaty M, et al. Photoselective vaporization of the prostate with the 180-W XPS-Greenlight laser: Five-year experience of safety, efficiency, and functional outcomes. Can Urol Assoc J. 2018 Jul;12(7):E318-E324
- Thomas JA, Tubaro A, Barber N, et al. A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH Study. Eur Urol. 2016 Jan;69(1):94-102.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.
Content of this web site is for Informational Purposes only and does not constitute medical advice and should not be used for medical diagnoses. Boston Scientific strongly recommends that you consult with your physician on all matters pertaining to your health or to address any clinical/medical questions.